Showing results (11-20 of 126) with videos related to
Sort By:
Pageof 13
Antiviral Therapy|July 24, 2012
Virological evidence supporting the use of raltegravir in HIV post-exposure prophylaxis regimensMatthew D Marsden, Paul A Krogstad, Jerome A ZackVirology|July 23, 2011
HIV latency is influenced by regions of the viral genome outside of the long terminal repeats and regulatory genesMatthew D Marsden, Bryan P Burke, Jerome A ZackAIDS Research and Human Retroviruses|November 13, 2008
Short communication: Activating stimuli enhance immunotoxin-mediated killing of HIV-infected macrophagesMatthew D Marsden, Jie Xu, Dean Hamer, et al.Antimicrobial Agents and Chemotherapy|June 2, 2011
Single mutations in HIV integrase confer high-level resistance to raltegravir in primary human macrophagesMatthew D Marsden, Patricia Avancena, Christina M R Kitchen, et al.Journal of Virology|May 4, 2007
Primary cell model for activation-inducible human immunodeficiency virusBryan Burke, Helen J Brown, Matthew D Marsden, et al.Nature Chemistry|August 24, 2012
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitroBrian A DeChristopher, Brian A Loy, Matthew D Marsden, et al.Virology|February 26, 2023
Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversalJose A Moran, Alok Ranjan, Rami Hourani, et al.Stem Cells (Dayton, Ohio)|November 1, 2008
Generation of T lineage cells from human embryonic stem cells in a feeder free systemZoran Galić, Scott G Kitchen, Aparna Subramanian, et al.Journal of Virology|November 11, 2011
HIV latency in the humanized BLT mouseMatthew D Marsden, Michael Kovochich, Nuttee Suree, et al.Journal of Stem Cells|May 26, 2010
Macrophage differentiation from embryoid bodies derived from human embryonic stem cellsAparna Subramanian, Beichu Guo, Matthew D Marsden, et al.Pageof 13